Chemed Reports First-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Chemed Corporation (CHE) Tops Q1 EPS by 3c
April 28, 2020 4:21 PM EDTChemed Corporation (NYSE: CHE) reported Q1 EPS of $3.68, $0.03 better than the analyst estimate of $3.65. Revenue for the quarter came in at $516 million versus the consensus estimate of $520.18 million.
Guidance for 2020
Management anticipates providing updated 2020 earnings guidance in July 2020 as part of the June 30,... More
